
Diorasis Therapeutics Names Richard A. Kresch, MD to Board of Directors
Appointment Strengthens Company’s Expertise in Translational Medicine and Commercial Strategy Diorasis Therapeutics, a biotechnology company based in Boston and focused on developing durable gene therapies for glaucoma and other ophthalmic…












